Your browser doesn't support javascript.
loading
Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
Di Altobrando, A; Patrizi, A; Bardazzi, F.
  • Di Altobrando A; Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.
  • Patrizi A; Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.
  • Bardazzi F; Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.
J Eur Acad Dermatol Venereol ; 34(7): e295-e297, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32302437
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Vesícula / Inmunosupresores Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Vesícula / Inmunosupresores Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article